Expert Interview
Discussing enzyme replacement therapies such as Sanofi's Nexviazyme (avalglucosidase alfa-ngpt) and Amicus Therapeutics's Pombiliti + Opfolda(AT-GAA) with a specialist who treats patients with late-onset Pompe disease.
Ticker(s): FOLD, SNYInstitution: Mount Sinai
- Genetics and Genomics Pediatrician and assistant professor with a focus in metabloism, newborn screening, and mitochondrial disorders
- co-director of the Mitochondrial Medicine program in the division of Medical Genetics at the Mount Sinai
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
